AI assistant
Sending…
ELI LILLY & Co — Director's Dealing 2015
Jan 30, 2015
29745_dirs_2015-01-30_381672e9-bfd6-4e8a-8f97-7e38f41387f9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2015-01-28
Reporting Person: Walsh Fionnuala M (SVP, Global Quality)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-01-28 | Common Stock | A | 12535 | $70.97 | Acquired | 39028 | Direct |
| 2015-01-28 | Common Stock | A | 8369 | $70.97 | Acquired | 22578 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-01-28 | Restricted Stock Unit | $ | A | 4144 | Acquired | 2016-02-01 | Common Stock (4144.0) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 988 | Indirect |
| Common Stock | 1070 | Indirect |
Footnotes
F1: Reporting person disclaims beneficial ownership of these shares.
F2: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
More from ELI LILLY & Co
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
May 1
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 29